Amgen (AMGN)

R&D Expenses

$7.64B

TTM · Period ending: · USD

AMGN logo

AMGN R&D Expenses

Latest reported$7.64B
AMGN TTM R&D Expenses ($0.00 → $7.64B)
High-resolution chart · PNG

AMGN r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Amgen R&D Expenses — Trailing twelve months (TTM) (USD)
Period endingR&D Expenses (USD)
867,900,000
861,900,000
845,000,000
837,800,000
833,300,000
824,600,000
822,800,000
772,900,000
740,500,000
698,800,000
663,300,000
636,000,000
642,600,000
635,600,000
630,800,000
609,400,000
567,200,000
545,400,000
528,300,000
508,600,000
483,700,000
468,500,000
451,800,000
415,800,000
391,900,000
363,700,000
323,500,000
235,500,000
153,900,000
73,700,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.